| Year |
Citation |
Score |
| 2020 |
Bononi A, Goto K, Ak G, Yoshikawa Y, Emi M, Pastorino S, Carparelli L, Ferro A, Nasu M, Kim JH, Suarez JS, Xu R, Tanji M, Takinishi Y, Minaai M, ... ... Carbone M, et al. Heterozygous germline mutations increase susceptibility to asbestos and mesothelioma. Proceedings of the National Academy of Sciences of the United States of America. PMID 33318203 DOI: 10.1073/pnas.2019652117 |
0.499 |
|
| 2020 |
Carbone M, Harbour JW, Brugarolas J, Bononi A, Pagano I, Dey A, Krausz T, Pass HI, Yang H, Gaudino G. Biological Mechanisms and Clinical Significance of Mutations in Human Cancer. Cancer Discovery. PMID 32690542 DOI: 10.1158/2159-8290.Cd-19-1220 |
0.427 |
|
| 2020 |
Carbone M, Arron ST, Beutler B, Bononi A, Cavenee W, Cleaver JE, Croce CM, D'Andrea A, Foulkes WD, Gaudino G, Groden JL, Henske EP, Hickson ID, Hwang PM, Kolodner RD, et al. Tumour predisposition and cancer syndromes as models to study gene-environment interactions. Nature Reviews. Cancer. PMID 32472073 DOI: 10.1038/S41568-020-0265-Y |
0.379 |
|
| 2020 |
Carbone M, Gazdar A, Butel JS. SV40 and human mesothelioma. Translational Lung Cancer Research. 9: S47-S59. PMID 32206570 DOI: 10.21037/Tlcr.2020.02.03 |
0.392 |
|
| 2020 |
Lee HJ, Pham T, Chang MT, Barnes D, Cai AG, Noubade R, Totpal K, Chen X, Tran C, Hagenbeek T, Wu X, Eastham-Anderson J, Tao J, Lee W, Bastian BC, ... Carbone M, et al. The tumor suppressor BAP1 regulates the Hippo pathway in pancreatic ductal adenocarcinoma. Cancer Research. PMID 31988076 DOI: 10.1158/0008-5472.Can-19-1704 |
0.342 |
|
| 2019 |
Carbone M, Melino G. Stearoyl CoA Desaturase Regulates Ferroptosis in Ovarian Cancer Offering New Therapeutic Perspectives. Cancer Research. 79: 5149-5150. PMID 31615810 DOI: 10.1158/0008-5472.Can-19-2453 |
0.372 |
|
| 2019 |
Bertino P, Premeaux TA, Fujita T, Haun BK, Marciel MP, Hoffmann FW, Garcia A, Yiang H, Pastorino S, Carbone M, Niki T, Berestecky J, Hoffmann PR, Ndhlovu LC. Targeting the C-terminus of galectin-9 induces mesothelioma apoptosis and M2 macrophage depletion. Oncoimmunology. 8: 1601482. PMID 31413910 DOI: 10.1080/2162402X.2019.1601482 |
0.367 |
|
| 2019 |
Carbone M, Adusumilli PS, Alexander HR, Baas P, Bardelli F, Bononi A, Bueno R, Felley-Bosco E, Galateau-Salle F, Jablons D, Mansfield AS, Minaai M, de Perrot M, Pesavento P, Rusch V, et al. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. Ca: a Cancer Journal For Clinicians. PMID 31283845 DOI: 10.3322/Caac.21572 |
0.356 |
|
| 2019 |
Tsao MS, Carbone M, Galateau-Salle F, Moreira AL, Nicholson AG, Roden AC, Adjei AA, Aubry MC, Fennell DA, Gomez D, Harpole D, Hesdorffer M, Hirsch FR, Liu G, Malik S, et al. Pathologic considerations and standardization in mesothelioma clinical trials. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 31260832 DOI: 10.1016/J.Jtho.2019.06.020 |
0.323 |
|
| 2018 |
Carbone M, Yang H, Gaudino G. Does Chromothripsis Make Mesothelioma an Immunogenic Cancer? Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30598368 DOI: 10.1016/J.Jtho.2018.11.006 |
0.319 |
|
| 2018 |
Pastorino S, Yoshikawa Y, Pass HI, Emi M, Nasu M, Pagano I, Takinishi Y, Yamamoto R, Minaai M, Hashimoto-Tamaoki T, Ohmuraya M, Goto K, Goparaju C, Sarin KY, Tanji M, ... ... Carbone M, et al. A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018790352. PMID 30376426 DOI: 10.1200/Jco.2018.79.0352 |
0.584 |
|
| 2018 |
Daou S, Barbour H, Ahmed O, Masclef L, Baril C, Sen Nkwe N, Tchelougou D, Uriarte M, Bonneil E, Ceccarelli D, Mashtalir N, Tanji M, Masson JY, Thibault P, Sicheri F, ... ... Carbone M, et al. Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1. Nature Communications. 9: 4385. PMID 30349006 DOI: 10.1038/S41467-018-06854-2 |
0.314 |
|
| 2018 |
Carbone M, Amelio I, Affar EB, Brugarolas J, Cannon-Albright LA, Cantley LC, Cavenee WK, Chen Z, Croce CM, Andrea A, Gandara D, Giorgi C, Jia W, Lan Q, Mak TW, et al. Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine. Cell Death and Differentiation. PMID 30323273 DOI: 10.1038/S41418-018-0213-5 |
0.335 |
|
| 2018 |
Tsao AS, Lindwasser OW, Adjei AA, Adusumilli PS, Beyers M, Blumenthal GM, Bueno R, Burt BM, Carbone M, Dahlberg SE, de Perrot M, Fennell DA, Friedberg J, Gill RR, Gomez DR, et al. Current and Future Management of Malignant Mesothelioma : A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer and Mesothelioma Applied Research Foundation. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30266660 DOI: 10.1016/J.Jtho.2018.08.2036 |
0.319 |
|
| 2018 |
Mutti L, Peikert T, Robinson BWS, Scherpereel A, Tsao AS, de Perrot M, Woodard GA, Jablons DM, Wiens J, Hirsch FR, Yang H, Carbone M, Thomas A, Hassan R. State of the Art: Concise Review Scientific Advances and New Frontiers in Mesothelioma Therapeutics. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 29966799 DOI: 10.1016/J.Jtho.2018.06.011 |
0.364 |
|
| 2018 |
McCambridge AJ, Napolitano A, Mansfield AS, Fennell DA, Sekido Y, Nowak AK, Reungwetwattana T, Mao W, Pass HI, Carbone M, Yang H, Peikert T. State of the Art: Advances in Malignant Pleural Mesothelioma in 2017. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 29524617 DOI: 10.1016/J.Jtho.2018.02.021 |
0.358 |
|
| 2018 |
Emri AS, Esendagli D, Carbone M. Malignant Mesothelioma (MM) is still the leading cause of death in Karain villagers in Turkey and/or abroad due to erionite exposure European Respiratory Journal. 52. DOI: 10.1183/13993003.Congress-2018.Pa2876 |
0.372 |
|
| 2018 |
Carbone M, Bononi A, Giorgi C, Patergnani S, Pass HI, Jia W, Pinton P, Yang H. Abstract 5519: BAP1 modulates gene-environment interaction in carcinogenesis Cancer Research. 78: 5519-5519. DOI: 10.1158/1538-7445.Am2018-5519 |
0.398 |
|
| 2017 |
Szymiczek A, Carbone M, Pastorino S, Napolitano A, Tanji M, Minaai M, Pagano I, Mason JM, Pass HI, Bray MR, Mak TW, Yang H. Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma. Oncogene. PMID 28759042 DOI: 10.1038/Onc.2017.266 |
0.352 |
|
| 2017 |
Chen Z, Gaudino G, Pass HI, Carbone M, Yang H. Diagnostic and prognostic biomarkers for malignant mesothelioma: an update. Translational Lung Cancer Research. 6: 259-269. PMID 28713671 DOI: 10.21037/Tlcr.2017.05.06 |
0.355 |
|
| 2017 |
Carbone M, Yang H. Mesothelioma: recent highlights. Annals of Translational Medicine. 5: 238. PMID 28706906 DOI: 10.21037/Atm.2017.04.29 |
0.377 |
|
| 2017 |
Bononi A, Yang H, Giorgi C, Patergnani S, Pellegrini L, Su M, Xie G, Signorato V, Pastorino S, Morris P, Sakamoto G, Kuchay S, Gaudino G, Pass HI, Napolitano A, ... ... Carbone M, et al. Germline BAP1 mutations induce a Warburg effect. Cell Death and Differentiation. PMID 28665402 DOI: 10.1038/Cdd.2017.95 |
0.335 |
|
| 2017 |
Bononi A, Giorgi C, Patergnani S, Larson D, Verbruggen K, Tanji M, Pellegrini L, Signorato V, Olivetto F, Pastorino S, Nasu M, Napolitano A, Gaudino G, Morris P, Sakamoto G, ... ... Carbone M, et al. BAP1 regulates IP3R3-mediated Ca(2+) flux to mitochondria suppressing cell transformation. Nature. PMID 28614305 DOI: 10.1038/Nature22798 |
0.58 |
|
| 2017 |
Szymiczek A, Pastorino S, Larson D, Tanji M, Pellegrini L, Xue J, Li S, Giorgi C, Pinton P, Takinishi Y, Pass HI, Furuya H, Gaudino G, Napolitano A, Carbone M, et al. FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model. Journal of Translational Medicine. 15: 58. PMID 28298211 DOI: 10.1186/S12967-017-1158-Z |
0.395 |
|
| 2017 |
Pellegrini L, Xue J, Larson D, Pastorino S, Jube S, Forest KH, Saad-Jube ZS, Napolitano A, Pagano I, Negi VS, Bianchi ME, Morris P, Pass HI, Gaudino G, Carbone M, et al. HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma. Oncotarget. PMID 28186988 DOI: 10.18632/Oncotarget.15152 |
0.448 |
|
| 2017 |
Carbone M, Yoshikawa Y, Emi M, Hashimoto-Tamaoki T, Ohmuraya M, Sato A, Tsujimura T, Hasegawa S, Nakano T, Nasu M, Pastorino S, Szymiczek A, Bononi A, Pass HI, Yang H. Abstract 2553: High-density array-CGH with targeted NGS unmask multiple non-contiguous minute deletions on chromosome 3p21 in mesothelioma Cancer Research. 77: 2553-2553. DOI: 10.1158/1538-7445.Am2017-2553 |
0.543 |
|
| 2016 |
Napolitano A, Carbone M. Malignant Mesothelioma: Time to Translate? Trends in Cancer. 2: 467-474. PMID 28603777 DOI: 10.1016/J.Trecan.2016.07.004 |
0.382 |
|
| 2016 |
Guo Z, Carbone M, Zhang X, Su D, Sun W, Lou J, Gao Z, Shao D, Chen J, Zhang G, Hu J, Chen K, Wang F, Pass HI, Yu H, et al. Improving the accuracy of mesothelioma diagnosis in China. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28007630 DOI: 10.1016/J.Jtho.2016.12.006 |
0.328 |
|
| 2016 |
Mao W, Zhang X, Guo Z, Gao Z, Pass HI, Yang H, Carbone M. Association of Asbestos Exposure With Malignant Mesothelioma Incidence in Eastern China. Jama Oncology. PMID 27918607 DOI: 10.1001/Jamaoncol.2016.5487 |
0.329 |
|
| 2016 |
Yoshikawa Y, Emi M, Hashimoto-Tamaoki T, Ohmuraya M, Sato A, Tsujimura T, Hasegawa S, Nakano T, Nasu M, Pastorino S, Szymiczek A, Bononi A, Tanji M, Pagano I, Gaudino G, ... ... Carbone M, et al. High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma. Proceedings of the National Academy of Sciences of the United States of America. PMID 27834213 DOI: 10.1073/Pnas.1612074113 |
0.563 |
|
| 2016 |
Larson D, Powers A, Ambrosi JP, Tanji M, Napolitano A, Flores EG, Baumann F, Pellegrini L, Jennings CJ, Buck BJ, McLaurin BT, Merkler D, Robinson C, Morris P, Dogan M, ... ... Carbone M, et al. Investigating palygorskite's role in the development of mesothelioma in southern Nevada: Insights into fiber-induced carcinogenicity. Journal of Toxicology and Environmental Health. Part B, Critical Reviews. 19: 213-230. PMID 27705545 DOI: 10.1080/10937404.2016.1195321 |
0.355 |
|
| 2016 |
Baumann F, Carbone M. Environmental risk of mesothelioma in the United States: An emerging concern-epidemiological issues. Journal of Toxicology and Environmental Health. Part B, Critical Reviews. 19: 231-249. PMID 27705543 DOI: 10.1080/10937404.2016.1195322 |
0.307 |
|
| 2016 |
Carbone M, Kanodia S, Chao A, Miller A, Wali A, Weissman D, Adjei A, Baumann F, Boffetta P, Buck B, de Perrot M, Dogan AU, Gavett S, Gualtieri A, Hassan R, et al. Consensus Report of the 2015 Weinman International Conference on Mesothelioma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 11: 1246-62. PMID 27453164 DOI: 10.1016/J.Jtho.2016.04.028 |
0.401 |
|
| 2016 |
Carbone M, Shimizu D, Napolitano A, Tanji M, Pass HI, Yang H, Pastorino S. Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma. Oncotarget. PMID 27447750 DOI: 10.18632/Oncotarget.10653 |
0.373 |
|
| 2016 |
Ransohoff KJ, Jaju PD, Tang JY, Carbone M, Leachman S, Sarin KY. Familial skin cancer syndromes: Increased melanoma risk. Journal of the American Academy of Dermatology. 74: 423-34. PMID 26892652 DOI: 10.1016/J.Jaad.2015.09.070 |
0.331 |
|
| 2016 |
Napolitano A, Antoine DJ, Pellegrini L, Baumann F, Pagano IS, Pastorino S, Goparaju CM, Prokrym K, Canino C, Pass H, Carbone M, Yang H. HMGB1 and its hyper-acetylated isoform are sensitive and specific serum biomarkers to detect asbestos exposure and to identify mesothelioma patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26733616 DOI: 10.1158/1078-0432.Ccr-15-1130 |
0.306 |
|
| 2016 |
Napolitano A, Antoine DJ, Pellegrini L, Baumann F, Pagano I, Pastorino S, Goparaju CM, Prokrym K, Canino C, Pass HI, Carbone M, Yang H. Abstract 3112: HMGB1 and its isoform are sensitive and specific biomarkers to detect asbestos exposure and to identify mesothelioma patients Cancer Research. 76: 3112-3112. DOI: 10.1158/1538-7445.Am2016-3112 |
0.391 |
|
| 2016 |
Carbone M, Flores EG, Emi M, Gaudino G, Pastorino S, Yang H, Johnson T, Tsunoda T, Hesdorffer M, Pass HI. Abstract 1179: Combined genetic and genealogic studies uncover a large BAP1 cancer syndrome kindred, tracing back nine generations to a common ancestor from the 1700s Cancer Research. 76: 1179-1179. DOI: 10.1158/1538-7445.Am2016-1179 |
0.393 |
|
| 2015 |
Carbone M, Flores EG, Emi M, Johnson TA, Tsunoda T, Behner D, Hoffman H, Hesdorffer M, Nasu M, Napolitano A, Powers A, Minaai M, Baumann F, Bryant-Greenwood P, Lauk O, et al. Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s. Plos Genetics. 11: e1005633. PMID 26683624 DOI: 10.1371/Journal.Pgen.1005633 |
0.572 |
|
| 2015 |
Daou S, Hammond-Martel I, Mashtalir N, Barbour H, Gagnon J, Iannantuono NV, Sen Nkwe N, Motorina A, Pak H, Yu H, Wurtele H, Milot E, Mallette FA, Carbone M, Affar EB. The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and is Disrupted in Cancer. The Journal of Biological Chemistry. PMID 26416890 DOI: 10.1074/Jbc.M115.661553 |
0.327 |
|
| 2015 |
Bononi A, Napolitano A, Pass HI, Yang H, Carbone M. Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies. Expert Review of Respiratory Medicine. 9: 633-54. PMID 26308799 DOI: 10.1586/17476348.2015.1081066 |
0.35 |
|
| 2015 |
Klebe S, Driml J, Nasu M, Pastorino S, Zangiabadi A, Henderson D, Carbone M. BAP1 hereditary cancer predisposition syndrome: a case report and review of literature. Biomarker Research. 3: 14. PMID 26140217 DOI: 10.1186/S40364-015-0040-5 |
0.555 |
|
| 2015 |
Napolitano A, Pellegrini L, Dey A, Larson D, Tanji M, Flores EG, Kendrick B, Lapid D, Powers A, Kanodia S, Pastorino S, Pass HI, Dixit V, Yang H, Carbone M. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma. Oncogene. PMID 26119930 DOI: 10.1038/Onc.2015.243 |
0.374 |
|
| 2015 |
Yang H, Pellegrini L, Napolitano A, Giorgi C, Jube S, Preti A, Jennings CJ, De Marchis F, Flores EG, Larson D, Pagano I, Tanji M, Powers A, Kanodia S, Gaudino G, ... ... Carbone M, et al. Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression. Cell Death & Disease. 6: e1786. PMID 26068794 DOI: 10.1038/Cddis.2015.153 |
0.416 |
|
| 2015 |
Carbone M, Gaudino G, Yang H. Recent insights emerging from malignant mesothelioma genome sequencing. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 409-11. PMID 25695218 DOI: 10.1097/Jto.0000000000000466 |
0.34 |
|
| 2015 |
Baumann F, Buck BJ, Metcalf RV, McLaurin BT, Merkler DJ, Carbone M. The Presence of Asbestos in the Natural Environment is Likely Related to Mesothelioma in Young Individuals and Women from Southern Nevada. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 731-7. PMID 25668121 DOI: 10.1097/Jto.0000000000000506 |
0.314 |
|
| 2015 |
Nasu M, Emi M, Pastorino S, Tanji M, Powers A, Luk H, Baumann F, Zhang YA, Gazdar A, Kanodia S, Tiirikainen M, Flores E, Gaudino G, Becich MJ, Pass HI, ... ... Carbone M, et al. High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 565-76. PMID 25658628 DOI: 10.1097/Jto.0000000000000471 |
0.583 |
|
| 2015 |
Guo G, Chmielecki J, Goparaju C, Heguy A, Dolgalev I, Carbone M, Seepo S, Meyerson M, Pass HI. Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. Cancer Research. 75: 264-9. PMID 25488749 DOI: 10.1158/0008-5472.Can-14-1008 |
0.353 |
|
| 2015 |
Baumann F, Flores E, Napolitano A, Kanodia S, Taioli E, Pass H, Yang H, Carbone M. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis. 36: 76-81. PMID 25380601 DOI: 10.1093/Carcin/Bgu227 |
0.36 |
|
| 2015 |
Powers A, Carbone M. Diagnostic tools and staging of malignant pleural mesothelioma Lung Cancer Management. 4: 211-218. DOI: 10.2217/Lmt.15.25 |
0.339 |
|
| 2015 |
Yang H, Jube S, Carbone M. Abstract A36: Novel therapeutic approaches for human malignant mesothelioma Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-A36 |
0.451 |
|
| 2015 |
Flores E, Emi M, Johnson T, Tsunoda T, Behner D, Hoffman H, Hesdorffer M, Nasu M, Napolitano A, Baumann F, Yang H, Carbone M. Abstract 4796: A founder mutation in the BAP1 gene among four caucasian families with high incidences of malignant peritoneal mesothelioma and uveal melanoma: a molecular and genealogical study in a 10-generation BAP1 cancer syndrome kindred Cancer Research. 75: 4796-4796. DOI: 10.1158/1538-7445.Am2015-4796 |
0.599 |
|
| 2015 |
Nasu M, Pastorino S, Luk H, Flores E, Baumann F, Powers A, Kanodia S, Gaudino G, Zhang Y, Gazdar A, Yang H, Pass HI, Emi M, Carbone M. Abstract 3944: High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma Cancer Research. 75: 3944-3944. DOI: 10.1158/1538-7445.Am2015-3944 |
0.548 |
|
| 2014 |
Gaudino G, Yang H, Carbone M. HGF/Met Signaling Is a Key Player in Malignant Mesothelioma Carcinogenesis. Biomedicines. 2: 327-344. PMID 28548074 DOI: 10.3390/Biomedicines2040327 |
0.42 |
|
| 2014 |
Comertpay S, Pastorino S, Tanji M, Mezzapelle R, Strianese O, Napolitano A, Baumann F, Weigel T, Friedberg J, Sugarbaker P, Krausz T, Wang E, Powers A, Gaudino G, Kanodia S, ... ... Carbone M, et al. Evaluation of clonal origin of malignant mesothelioma. Journal of Translational Medicine. 12: 301. PMID 25471750 DOI: 10.1186/S12967-014-0301-3 |
0.787 |
|
| 2014 |
Zhang L, Comertpay S, Shimizu D, DeMay RM, Carbone M, Honda SA, Eaves JM. Axillary metaplastic breast carcinoma with ipsilateral pectoral invasive ductal carcinoma: an unusual presentation. Case Reports in Oncological Medicine. 2014: 938509. PMID 25364575 DOI: 10.1155/2014/938509 |
0.756 |
|
| 2014 |
Cioce M, Canino C, Goparaju C, Yang H, Carbone M, Pass HI. Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation. Cell Death & Disease. 5: e1167. PMID 24722292 DOI: 10.1038/Cddis.2014.136 |
0.321 |
|
| 2014 |
Rose AH, Bertino P, Hoffmann FW, Gaudino G, Carbone M, Hoffmann PR. Increasing dietary selenium elevates reducing capacity and ERK activation associated with accelerated progression of select mesothelioma tumors. The American Journal of Pathology. 184: 1041-9. PMID 24492200 DOI: 10.1016/J.Ajpath.2013.12.008 |
0.363 |
|
| 2014 |
Nasu M, Napolitano A, Pastorino S, Tanji M, Flores E, Baumann F, Powers A, Gaudino G, Pass HI, Yang H, Carbone M. Abstract 446: BAP1 mutation in mesothelioma and “BAP1 Cancer Syndrome” Cancer Research. 74: 446-446. DOI: 10.1158/1538-7445.Am2014-446 |
0.614 |
|
| 2014 |
Cioce M, Canino C, Goparaju C, Yang H, Carbone M, Pass HI. Abstract 4404: CSF-1R signaling drives mesothelioma stemness and chemoresistance Cancer Research. 74: 4404-4404. DOI: 10.1158/1538-7445.Am2014-4404 |
0.328 |
|
| 2014 |
Comertpay S, Mezzapelle R, Tanji M, Strianese O, Pass HI, Weigel T, Friedberg J, Sugarbaker P, Krausz T, Wang E, Gaudino G, Yang H, Powers A, Parsons B, Pastorino S, ... Carbone M, et al. Abstract 3188: Evaluation of clonal origin of malignant mesothelioma/polyclonal origin of malignant mesothelioma Cancer Research. 74: 3188-3188. DOI: 10.1158/1538-7445.Am2014-3188 |
0.418 |
|
| 2013 |
Qi F, Okimoto G, Jube S, Napolitano A, Pass HI, Laczko R, Demay RM, Khan G, Tiirikainen M, Rinaudo C, Croce A, Yang H, Gaudino G, Carbone M. Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling. The American Journal of Pathology. 183: 1654-66. PMID 24160326 DOI: 10.1016/J.Ajpath.2013.07.029 |
0.577 |
|
| 2013 |
Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G. BAP1 and cancer. Nature Reviews. Cancer. 13: 153-9. PMID 23550303 DOI: 10.1038/Nrc3459 |
0.407 |
|
| 2013 |
Bertino P, Panigada M, Soprana E, Bianchi V, Bertilaccio S, Sanvito F, Rose AH, Yang H, Gaudino G, Hoffmann PR, Siccardi A, Carbone M. Fowlpox-based survivin vaccination for malignant mesothelioma therapy. International Journal of Cancer. Journal International Du Cancer. 133: 612-23. PMID 23335100 DOI: 10.1002/Ijc.28048 |
0.329 |
|
| 2013 |
Jube SL, Rivera Z, Casalgrandi M, Bianchi M, Pass HI, Gaudino G, Carbone M, Yang H. Abstract 5557: BoxA and ethyl pyruvate offer novel therapeutic approaches for human malignant mesothelioma. Cancer Research. 73: 5557-5557. DOI: 10.1158/1538-7445.Am2013-5557 |
0.778 |
|
| 2013 |
Qi F, Okimoto G, Jube S, Pass HI, Laczko R, DeMay RM, Khan G, Tiirikainen M, Yang H, Gaudino G, Carbone M. Abstract 3588: Common and different effects induced in primary human mesothelial cells and mice exposed to chrysotile or crocidolite asbestos. Cancer Research. 73: 3588-3588. DOI: 10.1158/1538-7445.Am2013-3588 |
0.532 |
|
| 2013 |
Napolitano A, Pellegrini L, Jube S, Jennings CJ, Flores EG, Larson D, Negi VS, Pagano I, Tanji M, Powers A, Pastorino S, Pass HI, Bianchi ME, Carbone M, Yang H. Abstract C187: Salicylates suppress tumor growth via inhibition of HMGB1. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-C187 |
0.415 |
|
| 2013 |
Croce A, Musa M, Allegrina M, Rinaudo C, Baris YI, Dogan AU, Powers A, Rivera Z, Bertino P, Yang H, Gaudino G, Carbone M. Micro-Raman spectroscopy identifies crocidolite and erionite fibers in tissue sections Journal of Raman Spectroscopy. 44: 1440-1445. DOI: 10.1002/Jrs.4286 |
0.716 |
|
| 2012 |
Ostroff RM, Mehan MR, Stewart A, Ayers D, Brody EN, Williams SA, Levin S, Black B, Harbut M, Carbone M, Goparaju C, Pass HI. Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool Plos One. 7. PMID 23056237 DOI: 10.1371/Journal.Pone.0046091 |
0.358 |
|
| 2012 |
Carbone M, Ferris LK, Baumann F, Napolitano A, Lum CA, Flores EG, Gaudino G, Powers A, Bryant-Greenwood P, Krausz T, Hyjek E, Tate R, Friedberg J, Weigel T, Pass HI, et al. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. Journal of Translational Medicine. 10: 179. PMID 22935333 DOI: 10.1186/1479-5876-10-179 |
0.39 |
|
| 2012 |
Rivera Z, Ferrone S, Wang X, Jube S, Yang H, Pass HI, Kanodia S, Gaudino G, Carbone M. CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5352-63. PMID 22893632 DOI: 10.1158/1078-0432.Ccr-12-0628 |
0.753 |
|
| 2012 |
Jube S, Rivera ZS, Bianchi ME, Powers A, Wang E, Pagano I, Pass HI, Gaudino G, Carbone M, Yang H. Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Research. 72: 3290-301. PMID 22552293 DOI: 10.1158/0008-5472.Can-11-3481 |
0.772 |
|
| 2012 |
Carbone M, Yang H. Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 598-604. PMID 22065079 DOI: 10.1158/1078-0432.Ccr-11-2259 |
0.439 |
|
| 2012 |
Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA, Gazdar AF, Pass HI, Yang H. Malignant mesothelioma: facts, myths, and hypotheses. Journal of Cellular Physiology. 227: 44-58. PMID 21412769 DOI: 10.1002/Jcp.22724 |
0.38 |
|
| 2012 |
Zeyana R, Ferrone S, Wang X, Sandro J, Yang H, Gaudino G, Carbone M. Abstract 2514: CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma Cancer Research. 72: 2514-2514. DOI: 10.1158/1538-7445.Am2012-2514 |
0.429 |
|
| 2012 |
Jube S, Rivera Z, Bianchi M, Powers A, Wang E, Pagano I, Pass HI, Gaudino G, Carbone M, Yang H. Abstract 1557: High mobility group box 1 secretion supports tumor progression of human malignant mesothelioma Cancer Research. 72: 1557-1557. DOI: 10.1158/1538-7445.Am2012-1557 |
0.773 |
|
| 2011 |
Qi F, Carbone M, Yang H, Gaudino G. Simian virus 40 transformation, malignant mesothelioma and brain tumors. Expert Review of Respiratory Medicine. 5: 683-97. PMID 21955238 DOI: 10.1586/Ers.11.51 |
0.55 |
|
| 2011 |
Nasu M, Carbone M, Gaudino G, Ly BH, Bertino P, Shimizu D, Morris P, Pass HI, Yang H. Ranpirnase Interferes with NF-κB Pathway and MMP9 Activity, Inhibiting Malignant Mesothelioma Cell Invasiveness and Xenograft Growth. Genes & Cancer. 2: 576-84. PMID 21901170 DOI: 10.1177/1947601911412375 |
0.579 |
|
| 2011 |
Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, ... ... Carbone M, et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nature Genetics. 43: 1022-5. PMID 21874000 DOI: 10.1038/Ng.912 |
0.748 |
|
| 2011 |
Carbone M, Baris YI, Bertino P, Brass B, Comertpay S, Dogan AU, Gaudino G, Jube S, Kanodia S, Partridge CR, Pass HI, Rivera ZS, Steele I, Tuncer M, Way S, et al. Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proceedings of the National Academy of Sciences of the United States of America. 108: 13618-23. PMID 21788493 DOI: 10.1073/Pnas.1105887108 |
0.745 |
|
| 2011 |
Shukla A, Hillegass JM, MacPherson MB, Beuschel SL, Vacek PM, Butnor KJ, Pass HI, Carbone M, Testa JR, Heintz NH, Mossman BT. ERK2 is essential for the growth of human epithelioid malignant mesotheliomas. International Journal of Cancer. Journal International Du Cancer. 129: 1075-86. PMID 21710492 DOI: 10.1002/Ijc.25763 |
0.413 |
|
| 2011 |
Altomare DA, Menges CW, Xu J, Pei J, Zhang L, Tadevosyan A, Neumann-Domer E, Liu Z, Carbone M, Chudoba I, Klein-Szanto AJ, Testa JR. Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis. Plos One. 6: e18828. PMID 21526190 DOI: 10.1371/Journal.Pone.0018828 |
0.343 |
|
| 2011 |
Hillegass JM, Blumen SR, Cheng K, MacPherson MB, Alexeeva V, Lathrop SA, Beuschel SL, Steinbacher JL, Butnor KJ, Ramos-Niño ME, Shukla A, James TA, Weiss DJ, Taatjes DJ, Pass HI, ... Carbone M, et al. Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapy. International Journal of Cancer. Journal International Du Cancer. 129: 233-44. PMID 20830711 DOI: 10.1002/Ijc.25666 |
0.366 |
|
| 2011 |
Zeyana R, Ferrone S, Wang X, Jube S, Yang H, Gaudino G, Carbone M. Abstract 4579: CSPG4 monoclonal antibodies inhibit the growth of human malignant mesothelioma Cancer Research. 71: 4579-4579. DOI: 10.1158/1538-7445.Am2011-4579 |
0.448 |
|
| 2011 |
Altomare DA, Menges CW, Xu J, Pei J, Zhang L, Tadevosyan A, Neumann-Domer E, Liu Z, Carbone M, Chudoba I, Klein-Szanto AJ, Testa JR. Abstract 4312: Loss of Ink4a and Arf each contributes to increased susceptibility to asbestos-induced malignant mesothelioma development Cancer Research. 71: 4312-4312. DOI: 10.1158/1538-7445.Am2011-4312 |
0.326 |
|
| 2011 |
Jube S, Rivera Z, Gaudino G, Pass HI, Bianchi ME, Carbone M, Yang H. Abstract 2600: HMGB1, a potential new target for mesothelioma therapy Cancer Research. 71: 2600-2600. DOI: 10.1158/1538-7445.Am2011-2600 |
0.77 |
|
| 2010 |
Zhang L, Qi F, Gaudino G, Strianese O, Yang H, Morris P, Pass HI, Nerurkar VR, Bocchetta M, Carbone M. Tissue Tropism of SV40 Transformation of Human Cells: Role of the Viral Regulatory Region and of Cellular Oncogenes. Genes & Cancer. 1: 1008-20. PMID 21779427 DOI: 10.1177/1947601910395580 |
0.559 |
|
| 2010 |
Shukla A, Hillegass JM, MacPherson MB, Beuschel SL, Vacek PM, Pass HI, Carbone M, Testa JR, Mossman BT. Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin. Molecular Cancer. 9: 314. PMID 21159167 DOI: 10.1186/1476-4598-9-314 |
0.376 |
|
| 2010 |
Hillegass JM, Shukla A, Lathrop SA, MacPherson MB, Beuschel SL, Butnor KJ, Testa JR, Pass HI, Carbone M, Steele C, Mossman BT. Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model. Annals of the New York Academy of Sciences. 1203: 7-14. PMID 20716277 DOI: 10.1111/J.1749-6632.2010.05554.X |
0.354 |
|
| 2010 |
Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C, Franzoso G, Lotze MT, Krausz T, Pass HI, Bianchi ME, Carbone M. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proceedings of the National Academy of Sciences of the United States of America. 107: 12611-6. PMID 20616036 DOI: 10.1073/Pnas.1006542107 |
0.762 |
|
| 2010 |
Shukla A, Hillegass JM, MacPherson MB, Beuschel SL, Heintz NH, Vacek PM, Pass HI, Carbone M, Testa JR, Mossman BT. Abstract 347: Inhibition of ERK1/2 can sensitize human malignant mesothelioma cells and tumors to doxorubicin Cancer Research. 70: 347-347. DOI: 10.1158/1538-7445.Am10-347 |
0.386 |
|
| 2010 |
Chun SG, Yee NS, Qi F, Allsopp R, Davy PM, Fong KS, Carbone M, Bryant-Greenwood PK. Abstract 3209: The WRN RecQ helicase acts as a tumor suppressor in pancreatic adenocarcinoma Cancer Research. 70: 3209-3209. DOI: 10.1158/1538-7445.Am10-3209 |
0.593 |
|
| 2009 |
Pass HI, Carbone M. Current status of screening for malignant pleural mesothelioma. Seminars in Thoracic and Cardiovascular Surgery. 21: 97-104. PMID 19822280 DOI: 10.1053/J.Semtcvs.2009.06.007 |
0.336 |
|
| 2009 |
Shukla A, Bosenberg MW, MacPherson MB, Butnor KJ, Heintz NH, Pass HI, Carbone M, Testa JR, Mossman BT. Activated cAMP response element binding protein is overexpressed in human mesotheliomas and inhibits apoptosis. The American Journal of Pathology. 175: 2197-206. PMID 19815709 DOI: 10.2353/Ajpath.2009.090400 |
0.369 |
|
| 2009 |
Yang H, Nasu M, Strianese O, Rivera Z, Luecke L, Carbone M. The legacy of "miracle mineral": asbestos and cancer. Hawaii Medical Journal. 68: 18-20. PMID 19365925 |
0.741 |
|
| 2009 |
Altomare DA, Menges CW, Pei J, Zhang L, Skele-Stump KL, Carbone M, Kane AB, Testa JR. Activated TNF-alpha/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice. Proceedings of the National Academy of Sciences of the United States of America. 106: 3420-5. PMID 19223589 DOI: 10.1073/Pnas.0808816106 |
0.368 |
|
| 2008 |
Carbone M, Pannuti A, Zhang L, Testa JR, Bocchetta M. A novel mechanism of late gene silencing drives SV40 transformation of human mesothelial cells. Cancer Research. 68: 9488-96. PMID 19010924 DOI: 10.1158/0008-5472.Can-08-2332 |
0.335 |
|
| 2008 |
Bocchetta M, Carbone M. SV40 Tag/p53 complexes actively promote malignant cell growth of human mesothelial cells. Cellular Oncology : the Official Journal of the International Society For Cellular Oncology. 30: 455. PMID 18853526 DOI: 10.3233/Clo-2008-0446 |
0.322 |
|
| 2008 |
Yang H, Testa JR, Carbone M. Mesothelioma epidemiology, carcinogenesis, and pathogenesis. Current Treatment Options in Oncology. 9: 147-57. PMID 18709470 DOI: 10.1007/S11864-008-0067-Z |
0.414 |
|
| 2008 |
Pass HI, Brewer GJ, Dick R, Carbone M, Merajver S. A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results. The Annals of Thoracic Surgery. 86: 383-9; discussion 39. PMID 18640301 DOI: 10.1016/J.Athoracsur.2008.03.016 |
0.3 |
|
| 2008 |
Rivera Z, Strianese O, Bertino P, Yang H, Pass H, Carbone M. The relationship between simian virus 40 and mesothelioma. Current Opinion in Pulmonary Medicine. 14: 316-21. PMID 18520265 DOI: 10.1097/Mcp.0B013E3283018220 |
0.732 |
|
| 2008 |
Beck AK, Pass HI, Carbone M, Yang H. Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies. Future Oncology (London, England). 4: 341-9. PMID 18518759 DOI: 10.2217/14796694.4.3.341 |
0.389 |
|
| 2008 |
Bocchetta M, Eliasz S, De Marco MA, Rudzinski J, Zhang L, Carbone M. The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth. Cancer Research. 68: 1022-9. PMID 18281476 DOI: 10.1158/0008-5472.Can-07-5203 |
0.315 |
|
| 2008 |
Ramos-Nino ME, Blumen SR, Sabo-Attwood T, Pass H, Carbone M, Testa JR, Altomare DA, Mossman BT. HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra-1 pathway. American Journal of Respiratory Cell and Molecular Biology. 38: 209-17. PMID 17872495 DOI: 10.1165/Rcmb.2007-0206Oc |
0.302 |
|
| 2007 |
Carbone M, Albelda SM, Broaddus VC, Flores RM, Hillerdal G, Jaurand MC, Kjaerheim K, Pass HI, Robinson B, Tsao A. Eighth international mesothelioma interest group. Oncogene. 26: 6959-67. PMID 17496929 DOI: 10.1038/Sj.Onc.1210515 |
0.344 |
|
| 2007 |
Eliasz S, Carbone M, Bocchetta M. Simian virus 40 and cancer Oncology Reviews. 1: 131-140. DOI: 10.1007/S12156-007-0015-3 |
0.409 |
|
| 2006 |
Carbone M, Bedrossian CW. The pathogenesis of mesothelioma. Seminars in Diagnostic Pathology. 23: 56-60. PMID 17044196 DOI: 10.1053/J.Semdp.2006.08.002 |
0.413 |
|
| 2006 |
Rdzanek M, Fresco R, Pass HI, Carbone M. Spindle cell tumors of the pleura: differential diagnosis. Seminars in Diagnostic Pathology. 23: 44-55. PMID 17044195 DOI: 10.1053/J.Semdp.2006.06.002 |
0.356 |
|
| 2006 |
Kroczynska B, Cutrone R, Bocchetta M, Yang H, Elmishad AG, Vacek P, Ramos-Nino M, Mossman BT, Pass HI, Carbone M. Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proceedings of the National Academy of Sciences of the United States of America. 103: 14128-33. PMID 16966607 DOI: 10.1073/Pnas.0604544103 |
0.39 |
|
| 2006 |
Yang H, Bocchetta M, Kroczynska B, Elmishad AG, Chen Y, Liu Z, Bubici C, Mossman BT, Pass HI, Testa JR, Franzoso G, Carbone M. TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proceedings of the National Academy of Sciences of the United States of America. 103: 10397-402. PMID 16798876 DOI: 10.1073/Pnas.0604008103 |
0.317 |
|
| 2006 |
Ramos-Nino ME, Testa JR, Altomare DA, Pass HI, Carbone M, Bocchetta M, Mossman BT. Cellular and molecular parameters of mesothelioma. Journal of Cellular Biochemistry. 98: 723-34. PMID 16795078 DOI: 10.1002/Jcb.20828 |
0.441 |
|
| 2006 |
Dogan AU, Baris YI, Dogan M, Emri S, Steele I, Elmishad AG, Carbone M. Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. Cancer Research. 66: 5063-8. PMID 16707428 DOI: 10.1158/0008-5472.Can-05-4642 |
0.397 |
|
| 2006 |
Yang H, Bocchetta M, Kroczynska B, Elmishad A, Chen Y, Liu Z, Bubici C, Mossman B, Pass H, Testa J, Franzoso G, Carbone M. 87 TNF-α inhibits asbestos induced cytotoxicity via a NF-kB dependent pathway: A possible mechanism for asbestos-induced oncogenesis Lung Cancer. 54: S21. DOI: 10.1016/S0169-5002(07)70163-0 |
0.304 |
|
| 2005 |
Suzuki M, Toyooka S, Shivapurkar N, Shigematsu H, Miyajima K, Takahashi T, Stastny V, Zern AL, Fujisawa T, Pass HI, Carbone M, Gazdar AF. Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Oncogene. 24: 1302-8. PMID 15592515 DOI: 10.1038/Sj.Onc.1208263 |
0.323 |
|
| 2004 |
Pass HI, Bocchetta M, Carbone M. Evidence of an important role for SV40 in mesothelioma. Thoracic Surgery Clinics. 14: 489-95. PMID 15559055 DOI: 10.1016/J.Thorsurg.2004.06.003 |
0.337 |
|
| 2004 |
Carbone M, Pass HI. Multistep and multifactorial carcinogenesis: when does a contributing factor become a carcinogen? Seminars in Cancer Biology. 14: 399-405. PMID 15489132 DOI: 10.1016/J.Semcancer.2004.06.002 |
0.416 |
|
| 2004 |
Carbone M, Gruber J, Wong M. Modern criteria to establish human cancer etiology. Seminars in Cancer Biology. 14: 397-8. PMID 15489131 DOI: 10.1016/J.Semcancer.2004.06.001 |
0.328 |
|
| 2004 |
Bocchetta M, Carbone M. Epidemiology and molecular pathology at crossroads to establish causation: molecular mechanisms of malignant transformation. Oncogene. 23: 6484-91. PMID 15322519 DOI: 10.1038/Sj.Onc.1207855 |
0.36 |
|
| 2004 |
Carbone M, Klein G, Gruber J, Wong M. Modern criteria to establish human cancer etiology. Cancer Research. 64: 5518-24. PMID 15289363 DOI: 10.1158/0008-5472.Can-04-0255 |
0.386 |
|
| 2004 |
Pass HI, Vogelzang N, Hahn S, Carbone M. Malignant pleural mesothelioma. Current Problems in Cancer. 28: 93-174. PMID 15197388 DOI: 10.1016/J.Currproblcancer.2004.04.001 |
0.336 |
|
| 2004 |
Carbone M, Bocchetta M. SV40 and Notch-I: multi-functionality meets pleiotropy Progress in Molecular and Subcellular Biology. 36: 289-305. PMID 15171617 DOI: 10.1007/978-3-540-74264-7_14 |
0.395 |
|
| 2004 |
Carbone M, Rdzanek MA. Pathogenesis of malignant mesothelioma. Clinical Lung Cancer. 5: S46-50. PMID 15117424 DOI: 10.3816/Clc.2004.S.002 |
0.399 |
|
| 2003 |
Gazdar AF, Carbone M. Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40. Clinical Lung Cancer. 5: 177-81. PMID 14667274 DOI: 10.3816/Clc.2003.N.031 |
0.387 |
|
| 2003 |
Carbone M, Pass HI, Miele L, Bocchetta M. New developments about the association of SV40 with human mesothelioma Oncogene. 22: 5173-5180. PMID 12910254 DOI: 10.1038/Sj.Onc.1206552 |
0.364 |
|
| 2003 |
Bocchetta M, Miele L, Pass HI, Carbone M. Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. Oncogene. 22: 81-9. PMID 12527910 DOI: 10.1038/Sj.Onc.1206097 |
0.344 |
|
| 2002 |
Powers A, Carbone M. The role of environmental carcinogens, viruses and genetic predisposition in the pathogenesis of mesothelioma. Cancer Biology & Therapy. 1: 348-53. PMID 12432244 DOI: 10.4161/Cbt.1.4.4 |
0.395 |
|
| 2002 |
Emri S, Demir A, Dogan M, Akay H, Bozkurt B, Carbone M, Baris I. Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicology Letters. 127: 251-7. PMID 12052665 DOI: 10.1016/S0378-4274(01)00507-0 |
0.346 |
|
| 2002 |
Foddis R, De Rienzo A, Broccoli D, Bocchetta M, Stekala E, Rizzo P, Tosolini A, Grobelny JV, Jhanwar SC, Pass HI, Testa JR, Carbone M. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene. 21: 1434-42. PMID 11857086 DOI: 10.1038/Sj.Onc.1205203 |
0.349 |
|
| 2002 |
Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Seminars in Oncology. 29: 2-17. PMID 11836664 DOI: 10.1053/Sonc.2002.30227 |
0.446 |
|
| 2002 |
Carbone M, Pass HI. Re: Debate on the link between SV40 and human cancer continues. Journal of the National Cancer Institute. 94: 229-30. PMID 11830615 DOI: 10.1093/Jnci/94.3.229-A |
0.329 |
|
| 2001 |
Rizzo P, Bocchetta M, Powers A, Foddis R, Stekala E, Pass HI, Carbone M. SV40 and the pathogenesis of mesothelioma. Seminars in Cancer Biology. 11: 63-71. PMID 11243900 DOI: 10.1006/Scbi.2000.0347 |
0.394 |
|
| 2000 |
Bocchetta M, Di Resta I, Powers A, Fresco R, Tosolini A, Testa JR, Pass HI, Rizzo P, Carbone M. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proceedings of the National Academy of Sciences of the United States of America. 97: 10214-9. PMID 10954737 DOI: 10.1073/Pnas.170207097 |
0.349 |
|
| 2000 |
Xiao SY, Rizzo P, Carbone M. Benign papillary mesothelioma of the tunica vaginalis testis Archives of Pathology and Laboratory Medicine. 124: 143-147. PMID 10629148 DOI: 10.1043/0003-9985(2000)124<0143:Bpmott>2.0.Co;2 |
0.352 |
|
| 1999 |
Rizzo P, Carbone M, Fisher SG, Matker C, Swinnen LJ, Powers A, Di Resta I, Alkan S, Pass HI, Fisher RI. Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest. 116: 470S-473S. PMID 10619511 DOI: 10.1378/Chest.116.Suppl_3.470S |
0.324 |
|
| 1999 |
Carbone M. Simian virus 40 and human tumors: It is time to study mechanisms Journal of Cellular Biochemistry. 76: 189-193. PMID 10618636 DOI: 10.1002/(Sici)1097-4644(20000201)76:2<189::Aid-Jcb3>3.0.Co;2-J |
0.398 |
|
| 1999 |
Krynska B, Del Valle L, Croul S, Gordon J, Katsetos CD, Carbone M, Giordano A, Khalili K. Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proceedings of the National Academy of Sciences of the United States of America. 96: 11519-24. PMID 10500209 DOI: 10.1073/Pnas.96.20.11519 |
0.335 |
|
| 1999 |
Carbone M, Fisher S, Powers A, Pass HI, Rizzo P. New molecular and epidemiological issues in mesothelioma: role of SV40. Journal of Cellular Physiology. 180: 167-72. PMID 10395286 DOI: 10.1002/(Sici)1097-4652(199908)180:2<167::Aid-Jcp4>3.0.Co;2-Q |
0.403 |
|
| 1997 |
Carbone M, Rizzo P, Pass HI. Simian virus 40, poliovaccines and human tumors: A review of recent developments Oncogene. 15: 1877-1888. PMID 9365233 DOI: 10.1038/Sj.Onc.1201375 |
0.35 |
|
| 1997 |
De Luca A, Baldi A, Esposito V, Howard CM, Bagella L, Rizzo P, Caputi M, Pass HI, Giordano GG, Baldi F, Carbone M, Giordano A. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nature Medicine. 3: 913-6. PMID 9256285 DOI: 10.1038/Nm0897-913 |
0.359 |
|
| 1997 |
Carbone M, Rizzo P, Grimley PM, Procopio A, Mew DJ, Shridhar V, de Bartolomeis A, Esposito V, Giuliano MT, Steinberg SM, Levine AS, Giordano A, Pass HI. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nature Medicine. 3: 908-12. PMID 9256284 DOI: 10.1038/Nm0897-908 |
0.386 |
|
| 1992 |
Cicala C, Pompetti F, Nguyen P, Dixon K, Levine AS, Carbone M. SV40 small t deletion mutants preferentially transform mononuclear phagocytes and B lymphocytes in vivo. Virology. 190: 475-9. PMID 1529547 DOI: 10.1016/0042-6822(92)91237-O |
0.31 |
|
| 1990 |
Carbone M, Levine AS. Oncogenes, antioncogenes, and the regulation of cell growth. Trends in Endocrinology and Metabolism: Tem. 1: 248-53. PMID 18411127 DOI: 10.1016/1043-2760(90)90005-N |
0.374 |
|
| 1988 |
Haddada H, Sogn JA, Coligan JE, Carbone M, Dixon K, Levine AS, Lewis AM. Viral gene inhibition of class I major histocompatibility antigen expression: not a general mechanism governing the tumorigenicity of adenovirus type 2-, adenovirus type 12-, and simian virus 40-transformed Syrian hamster cells. Journal of Virology. 62: 2755-61. PMID 2839700 DOI: 10.1128/Jvi.62.8.2755-2761.1988 |
0.333 |
|
| Show low-probability matches. |